 MedPage Today | Novartis nabs another FDA-approved indication for everolimus FiercePharma Turns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everolimus is one of the Swiss drugmaker's lead drugs in the ... FDA Approves Everolimus for Liver Rejection Novartis' Zortress cleared by FDA for liver transplants Novartis drug Zortress is first in over a decade approved by FDA to prevent ... |
